Exploring virus release as a bottleneck for the spread of influenza A virus infection in vitro and the implications for antiviral therapy with neuraminidase inhibitors

Avian influenza viruses that cause highly virulent infections in humans exhibit distinct replicative properties in contrast to human H1N1 viruses

(2016) Philippe F. Simon et al.   Scientific Reports

Clinical Implications of Antiviral Resistance in Influenza

(2015) Timothy Li et al.   Viruses-Basel

Impact of the H275Y and I223V Mutations in the Neuraminidase of the 2009 Pandemic Influenza Virus In Vitro and Evaluating Experimental Reproducibility

(2015) Eric G. Paradis et al.   PLoS One

How sticky should a virus be? The impact of virus binding and release on transmission fitness using influenza as an example

(2014) A. Handel et al.   Journal of the Royal Society Interface

Favipiravir (T-705), a novel viral RNA polymerase inhibitor

(2013) Yousuke Furuta et al.   ANTIVIRAL RESEARCH

In vitro activity of favipiravir and neuraminidase inhibitor combinations against oseltamivir-sensitive and oseltamivir-resistant pandemic influenza A (H1N1) virus

(2013) E. Bart Tarbet et al.   ARCHIVES OF VIROLOGY

Assessing Mathematical Models of Influenza Infections Using Features of the Immune Response

(2013) Hana M. Dobrovolny et al.   PLoS One

Combination Antiviral Therapy for Influenza: Predictions From Modeling of Human Infections

(2012) Alan S. Perelson et al.   JOURNAL OF INFECTIOUS DISEASES

The H275Y Neuraminidase Mutation of the Pandemic A/H1N1 Influenza Virus Lengthens the Eclipse Phase and Reduces Viral Output of Infected Cells, Potentially Compromising Fitness in Ferrets

(2012) L. T. Pinilla et al.   JOURNAL OF VIROLOGY

Identifying viral parameters from in vitro cell cultures

(2012) Shingo Iwami et al.   Frontiers in Microbiology

Design considerations in buildingin silicoequivalents of common experimental influenza virus assays

(2011) Benjamin P. Holder et al.   AUTOIMMUNITY

A review of mathematical models of influenza A infections within a host or cell culture: lessons learned and challenges ahead

(2011) Catherine AA Beauchemin et al.   BMC PUBLIC HEALTH

Exploring the effect of biological delays in kinetic models of influenza within a host or cell culture

(2011) Benjamin P Holder et al.   BMC PUBLIC HEALTH

Assessing the In Vitro Fitness of an Oseltamivir-Resistant Seasonal A/H1N1 Influenza Strain Using a Mathematical Model

(2011) Benjamin P. Holder et al.   PLoS One

Triple Combination Antiviral Drug (TCAD) Composed of Amantadine, Oseltamivir, and Ribavirin Impedes the Selection of Drug-Resistant Influenza A Virus

(2011) Justin D. Hoopes et al.   PLoS One

Neuraminidase inhibitors for treatment of human and avian strain influenza: A comparative modeling study

(2010) Hana M. Dobrovolny et al.   JOURNAL OF THEORETICAL BIOLOGY

Higher Level of Replication Efficiency of 2009 (H1N1) Pandemic Influenza Virus than Those of Seasonal and Avian Strains: Kinetics from Epithelial Cell Culture and Computational Modeling

(2010) H. Mitchell et al.   JOURNAL OF VIROLOGY

Rapid Emergence of Protease Inhibitor Resistance in Hepatitis C Virus

(2010) L. Rong et al.   Science Translational Medicine

The Evolution of Influenza Resistance and Treatment

(2009) David M. Weinstock   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Modeling amantadine treatment of influenza A virus in vitro

(2008) Catherine A.A. Beauchemin et al.   JOURNAL OF THEORETICAL BIOLOGY